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BECAUSE OF the high failure rate after renal 
homotransplantation, there has been an air 
of pessimism concerning the possibility of 
long term function of the grafted kidney. 
The immunologic processes subserving re- 
jection are generally thought to be so power- 
ful and persevering that consistent success 
cannot be expected with the use of any of the 
currently available methods of antirejection 
therapy. 
Recent personal experience in caring for 
patients with renal homografts has resulted 
in alterations in many of our preconceived 
notions concerning the management of such 
patients. I t  has led to the beliefs that the re- 
jection process can almost never be entirely 
prevented, but that its effects can be re- 
versed with a high degree of regularity and 
completeness. Furtnermore, the sumequent 
behavior 01 patients who have been brought 
through a successfully treated rejection crisis 
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suggests the early development of some de- 
gree of host-graft adaptation, since the 
phenomenon of vigorous secondary rejection 
$as been encountered only once. 
METHODS 
The material consists of our first 10 pa- 
tients who received renal homografts from 
living donors. All recipients were males. The 
operations were performed between 24 
November 1962 and 15 May 1963. The pa- 
tients have been followed up to 1 July 1963. 
Excluded from consideration are 2 patients 
in whom cadaveric kidneys were used as well 
as a homotransplantation between identical 
twins, which has been described previously 
(16). The 10 patients have in common that 
the homografts were previously normal 
organs and that injury during transfer 
was minimized by the provision of cooling 
during the average ischemic period of 39 
minutes. There was one donation from 
mother to son, and there were 5 from 
siblings, including 2 pairs of fraternal twins. 
In the other 4 patients, there was no genetic 
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TABLE I.-DATA REGARDING 10 PATIENTS WHO to 3), either starting at this level, or with 
RECEIVED RENAT. HOMOGRAFTS FROM LIVING a sharp increase in dose as in Patients 2 and 
DONORS 
d , c t ! h e  
Pat i~n l  Date o f  
Donor 
Mother 
Sister 
Frat. twin 
Wife 
Unrelated 
Brother 
Wife 
Brother 
Frat. twin 
Unrelated 
_ R r j ~ r l z n n  rz 
Onsel 
14th day 
25th day 
None 
Unable to 
assess 
Early death 
18th dav 
18th day 
4th day 
5th day 
34th day 
4th 
ISES--- 
Dz~ratzon 
20 days 
31 days 
19 days 
27 days 
35 days 
10 days 
Receding 
Receding 
relationship (Table I). In half the patients, 
the donor was of a different blood type than 
the recipient and in 4, of a different sex, 
factors which did not materially influence 
the results. 
Transplantation was performed with the 
technique of Murray and Harrison (1 2), and 
the kidney was placed in the contralateral 
iliac fossa. One to 19 days before operation, 
daily administration of azathioprine (imu- 
ran) in doses of 3 to 15 milligrams per 
kilogram of body weight was started in all 
but Patient 1. Patient 1 was initially treated 
with total body irradiation (Fig. I) ,  and the 
administration of azathioprine was begun in 
the postoperative period. An attempt was 
made to provide the maximum daily dose 
which would not produce leukopenia. Ex- 
cept when its discontinuance became man- 
datory because of the development of pro- 
longed agranulocytosis, azathioprine was 
given each day for the entire subsequent 
course. At the time of rejection crisis, the 
dose was temporarily increased in most 
cases (Figs. 2 and 3). If complete reversal of 
rejection could not be achieved with the 
addition of the secondary drug therapy to be 
described, the dose of azathioprine was 
used to induce temporary leukopenia de- 
liberately. This extreme measure was neces- 
sary in only 2 patients-Patients 2 and 7. 
Prednisone was used for secondary anti- 
rejection therapy in all but Patient 3. At the 
time of active rejection, doses of 150 to 400 
milligrams per day were employed (Figs. 1 
7, who were already receiving maintenance 
steroid therapy (Fig. 2). As soon as clear 
evidence was available that reversal of re- 
jection had occurred, the dose of predni- 
sone was reduced. Antacid therapy was 
vigorously applied to prevent the develop- 
ment of steroid ulcers. Patient 4 differed 
from the others in that he was given large 
doses- 100 ~nilligrams per day-of predni- 
sone from the time of transplantation (Fig. 
4), rather than for the specific treatment of 
a rejection crisis. 
During a rejection crisis, actinomycin C 
was given intravenously in a dose of 400 
micrograms at intervals of 4 to 7 days. 
In addition to the pharmacologic treat- 
ment of rejection, the host lymphoid mass 
was reduced by surgical measures either 
prior to or at the time of transplantation. 
All 10 patients underwent splenectomy and 
all but Patients 7, 8, and 10 also underwent 
thymectomy. 
RESULTS 
Eight of the 10 recipients are alive on 1 
July 1963, from 218 to 46 days after trans- 
plantation. A ninth patient, Patient 4, died 
113 days after operation from an unrecog- 
nized intra-abdominal abscess. The tenth 
patient, Patient 5, had cardiac arrest during 
transplantation which was successfully treat- 
ed, but he died 10 days later of mediastinal 
cellulitis and septicemia. 
Diagnosis of rejection. The diagnosis of re- 
jection crisis is relatively easy provided that 
the homograft has functioned well from the 
beginning. In all but Patient 5 there was an 
immediate diuresis and prompt resolution of 
the pre-existing azotemia. A variable period 
of normal renal function then ensued, last- 
ing from 4 to 25 days, which was ultimately 
interrupted by an episode of acute renal 
failure. This characteristic sequence, rather 
than any single symptom or finding, was 
the most easily recognized feature of a re- 
jection crisis. The use of damaged donor 
. 
organs, in which acute tubular necrosis may 
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FIG. 1. Rejection crisis in Patient 1. Note transient oliguria, depression of creatinine clearance, 
and elevation in blood urea nitrogen, blood pressure, and urinary protein excretion. The changes 
were all reversible. The patient previously had undergone bilateral nephrectomy, splenectomy, 
and thymectomy. R, Dose total body irradiation; Acti-C, actinomycin C, each arrow equals 200 mi- 
crograms of actinomycin Cadministered intravenously. Imuran is synonymous with azathioprine. 
complicate the picture, leads to confusion developed. Ur inary  sodium excretion 
in planning therapy. We (17) have observed abruptly declined to as low as 8 milliequiva- 
this in the employment of cadaveric kidneys. lents per liter. Fluid retention and weight 
Several consequences of functional de- gain followed. The blood urea nitrogen rose 
terioration of the homograft were regularly and the creatinine clearance fell, often to 
observed (Figs. 1 to 3). The patients be- less than 10 milliliters per minute. The 
came oliguric or anuric. Severe hypertension urine protein excretion was increased. There 
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FIG. 2. Rejection crisis in Patient 2. Note temporary deterioration of renal function, coincident 
with fever and weight gain starting on the twenty-fifth day after transplantation. The patient was 
essentially anuric for 3 days. Acti-C, Actinomycin C, each arrow equals 200 micrograms; D, diay- 
sis. Imuran is synonymous with azathioprine. 
was variability in the rapidity with which the 
rejection syndrome developed. In some 
cases, several days were required. In others, 
the crisis was violent in onset, occurring 
within a few hours. In 1 patient, Patient 2, 
an intravenous pyelogram obtained just be- 
fore a severe rejection attempt revealed 
prompt and concentrated dye excretion 
(Fig. 5). Within the next 24 llours, a scvcre 
rejection crisis had fully developed (Fig. 2). 
There was also a marked febrile systemic 
response at the time of a rejection attempt. 
Temperatures often rose to 40 degrees C. 
or higher, with accompanying tachycardia. 
Malaise and mental depression were ob- 
served, and 2 patients made suicidal ges- 
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FIG. 3. Rejection crisis in Patient 6. Deterioration of renal function began 19 days after trans- 
plantation. All stigmas of rejection are present except for acute hypertension and weight gain, 
which were successfully prevented by medical treatment. Acti-C, Actinomycin C; LN, left nephrec- 
tomy at time of transplantation; RJV, right nephrectomy. Imuran is synonymous with azathioprine. 
tures a t  this time. Leukocyte counts were patient, who received a homograft from his 
often strikingly elevated to as high as 45,000. wife, never had a definite episode of rejection 
Incidence of rejection crisis. Nine of the 10 (Fig. 4). This patient was the only one in 
patients survived the immediate postopera- the series who received massive steroid 
tive course. Of these, 7 experienced a severe therapy prophylactically, 100 milligrams of 
and unequivocal rejection crisis. An eighth prednisone per day. Histologic studies of his 
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FIG. 4. Course of Patient 4, the only patient who received large continuous prophylactic doses 
of prednisone from the time of operation. Despite provision of kidney by a genetically nonrelated 
donor, a definite rejection crisis did not occur. D, Dialysis; TS & BLN, thymectomy, splenectomy, 
and bilateral nephrectomy; Acti-C, actinomycin C, each arrow equals 200 micrograms of actino- 
mycin C administered intravenously. Patient ultimately died of unrecognized intra-abdominal abscess. 
homograft at autopsy, 113 days after trans- 
plantation, showed excellent preservation 
of architecture (Fig. 6). A few scattered foci 
of mononuclear cells were present. I t  is 
noteworthy that renal function was ade- 
quate until death resulted from sepsis. Pa- 
tients 2 and 7 received smaller prophylactic 
doses of prednisone-30 milligrams per day. 
In the latter patients, there was no demon- 
strable deterrent effect against rejection. 
The other patient in the series who did not 
undergo an  episode of rejection, Patient 3, 
received a kidney from his fraternal twin. 
There was a high degree of blood typing 
compatibility between the twins, extending 
to 21 of 23 minor subgroups. The other 
fraternal twin in the series, Patient 9, passed 
through an early severe rejection crisis and is 
currently recovering from a vigorous second- 
ary rejection attempt. 
Incidence o f  recurrent rejection crisis. A clear- 
cut secondary recurrence of renal failure 
was seen only in Patient 9. A presumed re- 
jection crisis began on the fifth day and was 
readily reversed (Table I). On the thirty- 
fourth day after transplantation, an almost 
identical episode occurred, with fever and 
deterioration of renal function. Reversal of 
rejection was considerably more difficult on 
the second than on the first occasion, and the 
completeness of remission in this patient is 
still in doubt. 
T h e  predictability of rejection reversal. Each of 
the 8 patients whose homograft was threat- 
ened by rejection was successfully treated, in 
terms of improvement of renal function. The 
promptness of a demonstrable response to 
therapy was variable. Although the return 
of renal function did not occur immediately, 
return to a normothermic state was in- 
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variably noted within a few hours after the 
administration of prednisone was started. 
There was value in studying several 
parameters of renal function during re- 
covery from a rejection crisis. Blood urea 
nitrogen was often slow to return to com- 
pletely normal values, the decline stopping 
at 30 to 40 milligrams per cent. Usually this 
was explicable by excessive protein break- 
down produced by the massive steroid 
therapy, since creatinine clearance and 
total urea excretion were normal at this 
time. The blood urea nitrogen returned to 
normal under these circumstances as the 
doses of steroids were reduced. 
The degree of permanent functional 
damage to the kidney was either minimal or 
undetectable in the cases available for the 
longest follow-up. Tile most serious sequela 
was seen in Patient 1, consisting of the ex- 
cretion of 2 to 4 grams of protein per day. 
Even in this patient, however, the blood 
urea nitrogen and creatinine clearances are 
normal. An intravenous pyelogram obtained 
after reversal of the rejection revealed 
prompt concentration of the dye (Fig. 7). 
DISCUSSION 
As commonly used, the term ' rejection 
carries an implication of finality. The obser- 
vations herein reported indicate that this 
phenomenon is not necessarily such a de- 
cisive event. I t  has been demonstrated that 
the features of rejection can be reversed in 
most cases in humans, even when the de- 
gree of acute renal functional impairment is 
profound. The extent of permanent histo- 
logic damage produced by such an immuno- 
logic crisis is not known in the surviving pa- 
tients, inasmuch as renal biopsies have un- 
derstandably not been performed. However, 
the functional capacity of these salvaged 
homografts has eventually returned to es- 
sentially normal standards in most cases. 
The fact that rejection is not an all or 
none phenomenon was first suggested by 
the retransplantation experiments in dogs of 
Balankura and his associates. It  was found 
that renal homografts which were under- 
FIG. 5. Four minute intravenous pyelogram of Patient 
2 on 23 February 1963, 24 days after renal transplanta- 
tion to the right iliac fossa. Note prompt and concen- 
trated dye excretion. Within 24 hours after this roent- 
genogram was taken, the patient experienced a severe 
rejection crisis and became essentially anuric. Recovery 
was ultimately complete. 
going active rejection resumed function and 
their normal histologic appearance was re- 
stored, if they were retransplanted back to 
the original donor. Subsequent isolated 
observations by Calne (2), Murray (11, 
13, 14), Goodwin (4), Hume (7), and their 
associates have suggested the possibility of 
reversing a homograft reaction, in either 
dogs or man. 
I t  is hoped that increased knowledge 
about the reversibility of rejection will allow 
wider application of the use of homografts 
than has been possible in the past. In ad- 
dition, the prior knowledge that a rejection 
crisis is almost a certainty and that it can 
usually be managed by relatively conserva- 
tive means should serve as a deterrent to the 
excessive early use of measures which may 
cause fatal bone marrow depression. The 
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FIG. 6. Autopsy qpecimen of rcnal homograft in 
Patient 4. Renal function had been adequate until dcath 
from sepsis 113 days after transplantation. Note good 
preservation of renal architecture. Only a few scattered 
mononuclear cells were present. X 39. 
data collected by Goodwin and Martin (5) 
on all known cases of renal homotransplan- 
tation suggest that the natural tendency to 
apply marrow-depressant therapy to pre- 
vent the onset of rejection may have con- 
tributed heavily to unfavorable mortality 
statistics in the past. 
Successful treatment of a rejection crisis is 
evidently dependent upon the synergistic 
action of a combination of agents which are 
individually ineffective. The most important 
drug in the regimen is azathioprine, an 
imidazole derivative of 6-mercaptopurine 
which was first used by Calne and Murray 
(3) to potentiate homograft survival. In  
most cases, azathioprine was given as the 
sole therapy until the beginning of rejection 
in doses which did not cause leukopenia. 
With the onset of homograft deterioration, 
it is mandatory that azathioprine be con- 
tinued without a decrease and preferably 
with an increase in dose. This is possible only 
if previous therapy has not caused suppres- 
sion of the leukocyte count. Prednisone and 
actinomycin C are then added. 
If the combination of agents does not re- 
sult in satisfactory reversal of clinical re- 
jection, the doses of azathioprine are in- 
creased until the leukocyte count has fallen 
to low levels. This extreme measure has been 
necessary in 2 of the cases. When azathio- 
princ is used as described, the maximum 
doses in such refractory cases are reserved 
for the time of greatest need, during the ef- 
fort to reverse the events of rejection. If 
leukopenia results from this therapy, it is 
important to continue azathioprine at a re- 
duced dose level despite the risk of produc- 
ing fatal agranulocytosis rather than to dis- 
continue it altogether. Experience at this 
and other clinics has demonstrated that the 
homograft rejection can proceed with great 
vigor in spite of the presence of leukopenia, 
if day to day antirejection therapy is not 
provided. 
Of the secondary drugs, prednisone is 
probably the most important in altering the 
acute febrile illness which is precipitated 
by a rejection crisis. Temperature returns 
to normal within a few hours, and there is 
usually prompt evidence of improved renal 
function. The almost miraculous effect of 
prednisone at this critical time was first 
noted by Goodwin and his associates (4) in 
a recently reported clinical case, and con- 
firmed by Marchioro and his colleagues (8), 
who used dogs in experiments designed 
specifically to test the effect of steroids in re- 
versing rejection. The dose is probably 
important in obtaining the desired effect. In 
Patients 2 and 7 of the present series, 30 
milligrams of prednisone per day were given 
before and after transplantation despite 
which rejection proceeded. An increase in 
dose to 200 milligrams per day as well as 
the addition of actinomycin C promptly al- 
leviated the symptoms. In a third case 
doses of 100 milligrams per day were started 
before transplantation, and the rejection at- 
tempt was masked. I t  would, therefore, 
seem reasonable to believe that 30 milli- 
grams per day is insufficient, and that 
doses of 100 milligrams per day or more are 
required. Stringent antacid therapy is a pre- 
requisite with such intensive steroid therapy. 
The value of actinomycin C in reversal of 
rejection was first demonstrated by Calne, 
Alexandre, and Murray (2), and confirmed 
Star21 et al.: REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS 9 
in clinical use by Murray and his associates 
(14) and in the present series. The thera- 
peutic mechanism of this drug, which has a 
selective cytocidal action on lymphocytes, 
has not yet been clarified. I t  is possible that 
it inhibits subtle chronic damage to the 
kidney by acting against parenchymal 
lymphocytic infiltrates already present a t  
the time of the rejection crisis. I t  is note- 
worthy that both the secondary drugs, ac- 
tinomycin C and prednisone, can be used 
without fear of confusing the status of the 
bone marrow injury since neither is a de- 
pressant drug. 
The general medical care of the patient 
during the rejection crisis is of the utmost 
importance. The elevation of blood pressure 
which occurs at this time is treated with the 
usual antihypertensive drugs. With aggres- 
sive therapy, the hypertension can be pre- 
vented altogether in some patients (Fig. 3). 
Inadequate control of the blood pressure 
may result in irreversible parenchymal 
damage, as described by parsons and his 
colleagues, and as recently observed by us 
(9) in a cadaveric homograft. I t  is usually 
necessary to restrict salt and fluids. In the 
present series, acute pulmonary edema de- 
veloped in Patient 8 because of failure of 
fluid limitation. 
The clinical course of those patients who 
have survived a rejection crisis deserves 
special comment. A state of relative im- 
munologic nonreactivity seems to have been 
produced, which has lasted for as long as 6 
months. After successful management of the 
attempted rejection, the same drug regimen 
which did not prevent the initial attack on 
the homograft has been adequate for main- 
tenance therapy. I t  is not known whether this 
i is due to a change in the antigenic prop- erties of the homograft or to an alteration in the specific antibody response to the stimulus of the grafted tissue. The apparent host-graft adaptation does, however, pro- vide some hope for prolonged functional 
&viva1 . 
Two important questions remain un- 
answered from the present study. The first 
FIG. 7. 'I'hree minute intravenous pyelogram of Patient 
1 on 28 January 1963, 9% weeks after transplantation 
and 4 weeks after complete recovery from a rejection 
crisis. Note prompt and concentrated dye excretion in 
the kidney which is located in the right iliac fossa. 
concerns the biologic significance of the re- 
jection crisis as it applies to the long term 
survival of the homograft. If the graft repu- 
diation can be reversed by the addition of 
prednisone and actinomycin C to pre-exist- 
ing azathioprine therapy, it might seem 
reasonable to administer these agents pro- 
phylactically from the time of transplanta- 
tion. This approach may eventually prove 
to be advisable. I t  is also conceivable, how- 
ever, that the avoidance of a primary host- 
graft reaction by these means would prevent 
the adaptive process alluded to previously. 
The other unanswered question conce rne - -  7 
the possible role of thymectomy and splenec- 
tomy, first, in rendering the rejection crisis 
more controllable, and, second, in contribut- 
ing to the subsequent state of host-graft non- 
reactivity. Miller and Gunderson and their 
colleagues have published the 
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suggestions that the thymus and spleen gov- 
ern to some extent the organization of im- 
munologic response to antigenic stimuli un- 
der special experimental conditions. The 
importance, if any, of these adjuvant surgical 
measures in the achievement of a favorable 
outcome will eventually be clarified by com- 
parison of the present results with other clini- 
cal series in which thymectomy or splenec- 
tomy have not been performed. 
The application of the foregoing concepts 
to other than renal homografts may be of 
importance in the future. With the kidney, 
the functional status of the graft can be fol- 
lowed with precision following the specific 
parameters of urine volume, blood urea ni- 
trogen, creatinine clearance, urine protein 
and urea, and blood pressure. The onset of 
rejection can be defined with great accuracy, 
and the indicated treatment instituted. The 
use of pulmonary, hepatic, spleen, cardiac, 
and endocrine homografts will each require 
the establishment of specific measurements 
to guide appropriate antirejection therapy. 
It  would seem probable that the principles 
of reversal of rejection, as defined with the 
kidney, can eventually be applied to other 
organ homografts. 
Although recognition that the rejection 
reaction is a highly reversible phenomenon 
constitutes an important step in the ultimate 
solution of the homograft problem, it would 
be erroneous to conclude that the present 
methods of therapy are anything but imper- 
fect. The regimen used is not selective enough 
to permit acceptance of the homograft with- 
out seriously endangering the host at some 
time during the course, most commonly at 
the time of the rejection crisis. The rejection 
reaction can be controlled, but sometimes 
only at the expense of fatal sepsis, as in 
Patients 4 and 5. 
SUMMARY 
The rejection process in humans receiving 
renal homografts can seldom be entirely pre- 
vented. At varying periods after operation, 
acute deterioration of renal function signals 
the onset of graft repudiation, accompanied 
by fever and other evidence of a systemic 
response. The physiological derangements 
attending such a rejection crisis can be regu- 
larly reversed by the addition of actinomycin 
C and massive. doses of pred.nisone to pre- 
existing therapy with azathioprine. In 1 of 
the 10 patients, a similar reversal was possi- 
ble by the addition of actinomycin C and 
prednisone in a patient previously treated 
with total body irradiation. The degree of 
functional recovery has been essentially com- 
plete in those patients who could be fol- 
lowed up and observed carefully for the 
longest periods. 
A state of host-graft nonreactivity has 
seemed to follow the successful treatment of 
such a rejection crisis. Resumption of the 
same therapy which failed to prevent the 
initial attack on the graft has been sufficient 
- 
to prevent a secondary rejection attempt in 
all but 1 case. 
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